# Patient-derived-organoid (PDO) Guided Versus Conventional Therapy for Advanced Inoperable Abdominal Tumors

> **NCT05378048** · PHASE2 · WITHDRAWN · sponsor: **Chinese University of Hong Kong**

## Conditions studied

- Organoids

## Interventions

- **DRUG:** PDO-guided treatment
- **DRUG:** standard of care

## Key facts

- **NCT ID:** NCT05378048
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-07-04
- **Primary completion:** 2025-07-03
- **Final completion:** 2025-07-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** no funding support
- **Last updated:** 2023-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05378048

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05378048, "Patient-derived-organoid (PDO) Guided Versus Conventional Therapy for Advanced Inoperable Abdominal Tumors". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05378048. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*